Search Results - "Maia, Ana Luiza Chaves"

Liposomes Containing Gadodiamide: Preparation, Physicochemical Characterization, and In Vitro Cytotoxic Evaluation by Maia, Ana Luiza Chaves, Fernandes, Christian, de Oliveira, Cynthia Nara Pereira, Teixeira, Claudia Salviano, Oliveira, Mariana Silva, Soares, Daniel Cristian Ferreira, Ramaldes, Gilson Andrade

“…The aim of this study was to develop, characterize and assess the cytotoxic activity of pHsensitive (pHL-Gd), stealth pH-sensitive (SpHL-Gd), and conventional…”
Get more information

Thermosensitive liposomes containing cisplatin functionalized by hyaluronic acid: preparation and physicochemical characterization by Gomes, Isabela P., Malachias, Ângelo, Maia, Ana Luiza Chaves, Lages, Eduardo B., Ferreira, Felipe Alves, Alves, Ricardo J., Giuberti, Cristiane S., de Barros, Andre Luis B., Leite, Elaine A.

“…This study aimed to develop a thermosensitive liposomal formulation (TSL) functionalized with hyaluronic acid (HA), to encapsulate a hydrophilic drug, the…”
Get full text

In Vitro and Preclinical Antitumor Evaluation of Doxorubicin Liposomes Coated with a Cholesterol-Based Trimeric β-D-Glucopyranosyltriazole by Maciel E Silva, Aline Teixeira, Maia, Ana Luiza Chaves, Silva, Juliana de Oliveira, Miranda, Sued Eustáquio Mendes, Cantini, Talia Silva, de Barros, Andre Luis Branco, Soares, Daniel Crístian Ferreira, de Magalhães, Mariana Torquato Quezado, Alves, Ricardo José, Ramaldes, Gilson Andrade

“…The coating of liposomes with polyethyleneglycol (PEG) has been extensively discussed over the years as a strategy for enhancing the in vivo and in vitro…”
Get full text

Poly(-3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV): Current advances in synthesis methodologies, antitumor applications and biocompatibility by Tebaldi, Marli Luiza, Maia, Ana Luiza Chaves, Poletto, Fernanda, de Andrade, Fabricio Vieira, Soares, Daniel Cristian Ferreira

“…Polyhydroxyalkanoates (PHAs) are often used for fabrication of biocompatible and absorbable medical devices due to their high biocompatibility and…”
Get full text

Vincristine-loaded hydroxyapatite nanoparticles as a potential delivery system for bone cancer therapy by Maia, Ana Luiza Chaves, Ferreira, Carolina de Aguiar, Barros, André Luis Branco de, E Silva, Aline Teixeira Maciel, Ramaldes, Gilson Andrade, Silva Cunha Júnior, Armando da, Oliveira, Diogo Coelho de Pádua, Fernandes, Christian, Ferreira Soares, Daniel Crístian

“…Despite advances in the development of new therapeutic agents and diagnostic imaging techniques, the 5-year survival of osteosarcoma, the most common type of…”
Get full text

Thermosensitive Nanosystems Associated with Hyperthermia for Cancer Treatment by Pereira Gomes, Isabela, Aparecida Duarte, Jaqueline, Chaves Maia, Ana Luiza, Rubello, Domenico, Townsend, Danyelle M, Branco de Barros, André Luís, Leite, Elaine Amaral

“…Conventional chemotherapy regimens have limitations due to serious adverse effects. Targeted drug delivery systems to reduce systemic toxicity are a powerful…”
Get full text

Synthesis of cholesterol-based neoglycoconjugates and their use in the preparation of liposomes for active liver targeting by e Silva, Aline Teixeira Maciel, Maia, Ana Luiza Chaves, de Oliveira Silva, Juliana, de Barros, André Luis Branco, Soares, Daniel Crístian Ferreira, de Magalhães, Mariana Torquato Quezado, José Alves, Ricardo, Ramaldes, Gilson Andrade

“…Carbohydrate receptors on liver represent attractive targets for receptor-mediated delivery of nanostructured therapeutics. In this study, two new…”
Get full text

Quality attributes of CTVad1, a nanoemulsified adjuvant for phase I clinical trial of SpiN COVID-19 vaccine by Dias Assis, Bruna Rodrigues, Gomes, Isabela Pereira, de Castro, Júlia Teixeira, Rivelli, Graziella Gomes, de Castro, Natália Salazar, Gomez-Mendoza, Diana Paola, Bagno, Flávia Fonseca, Hojo-Souza, Natália Satchiko, Chaves Maia, Ana Luiza, Lages, Eduardo Burgarelli, da Fonseca, Flávio Guimaraes, Ribeiro Teixeira, Santuza Maria, Fernandes, Ana Paula, Gazzinelli, Ricardo Tostes, Castro Goulart, Gisele Assis

“…To develop, characterize and evaluate an oil/water nanoemulsion with squalene (CTVad1) to be approved as an adjuvant for the SpiN COVID-19 vaccine clinical…”
Get full text